16Oct
11Oct
Fermented Protein Could Be the Path to Sustainable Aquaculture
In 2013, Larry Feinberg and Chris Marx founded KnipBio with one goal in mind: sustainability. It’s an area Feinberg has been personally invested in for the last 15 years. A microbiologist by training, Feinberg previously worked for Waltham-based Mascoma, a corporation that produces cellulosic biofuel. Read more >>
11Oct
eSight and CNIB Announce National Partnership to Benefit Canadians with Sight Loss
In honour of World Sight Day, eSight, a Canadian-based world leader in vision technology, is proud to announce a new partnership with CNIB, a non-profit organization driven to change what it means to be blind today. The partnership, the first of its kind for eSight, will expand access of its flagship product, eSight 3, to individuals living with sight loss in Canada. Read more >>
11Oct
eSight 3 Approved on the U.S. Department of Veterans Affairs (VA) Federal Supply Schedule
eSight, a world leader in vision technology, announced the approval of eSight 3 – advanced sight-enhancing glasses for those living with visual impairments -- on the United States Department of Veterans Affairs (VA) Federal Supply Schedule (FSS). The registration allows eSight to be included on the FSS through December 2023. Read more >>
05Oct
Angel Insights Webinar Series
Upcoming Angel Capital Association webinar featuring Ziad Moukheiber, CEO of Boston Harbor Angels. Pre-Money Valuations: Do They Matter as Much as Many Angels Think? Read more >>
04Oct
September VC Funding Update: 54 Startups Raise More Than a Billion Dollars
The summer slump wore off in September with over 50 Boston startups raising north of a billion dollars in venture funding, including Platelet BioGenesis. Read more >>
04Oct
Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, announced the presentation of three abstracts at the American College of Rheumatology (“ACR”) 2019 Annual Meeting being held November 8-13, 2019 in Atlanta, Georgia. Read more >>
03Oct
Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening
Xylyx Bio, a pioneer in tissue-specific extracellular matrix biomaterials, today announced the development of substrates for anti-fibrotic drug discovery as the next stage of its pipeline of pre-clinical cell culture products. Read more >>
03Oct
MarTech Interview with Lynn Browne and Mollie Kehoe, Co-Founders at BrandVerge
How did you get into technology? What inspired you to start BrandVerge? Lynn: I think what really inspired us to do both, is personal frustration in our professional careers. Mollie: When we sat down and really thought about it, there’s so many technologies that have disrupted and helped make our personal lives easier. Read more >>
03Oct